| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenues | $50K+0.0% | $50K+0.0% | $50K-99.9% | $40.0M-34.1% | $60.7M+20918.7% | $289K | $0 | $0 |
| Research and development | $134.9M-39.4% | $222.5M+0.9% | $220.6M+62.7% | $135.6M+64.7% | $82.3M+9.9% | $74.9M+47.3% | $50.8M-99.9% | $101.18B |
| General and administrative | $59.4M-11.6% | $67.2M+8.7% | $61.8M+23.9% | $49.9M+7.7% | $46.3M+19.7% | $38.7M+8.3% | $35.7M-99.9% | $42.48B |
| Restructuring costs | $30.1M | $0 | $0 | — | — | — | -$61K-100.0% | $16.14B |
| Total operating expenses | $224.3M-22.6% | $289.7M+2.6% | $282.4M+52.3% | $185.5M+44.2% | $128.6M+13.2% | $113.6M+31.3% | $86.5M-99.9% | $159.81B |
| Loss from operations | -$214.6M-38.9% | -$154.6M+19.1% | -$191.0M-45.2% | -$131.6M-282.8% | $72.0M+163.8% | -$112.7M-31.5% | -$85.7M+99.9% | -$158.85B |
| Interest income | $14.1M-45.2% | $25.8M-16.8% | $31.0M+388.5% | $6.3M+15016.7% | $42K-96.9% | $1.4M-83.3% | $8.2M-99.7% | $2.69B |
| Other expense, net | -$328K-77.3% | -$185K+59.6% | -$458K-15.4% | -$397K-313.5% | -$96K-54.8% | -$62K-131.6% | $196K-99.6% | $48.0M |
| Total other income, net | $13.8M-46.1% | $25.6M-16.1% | $30.6M+413.4% | $6.0M+11122.2% | -$54K-104.1% | $1.3M-84.4% | $8.4M-99.7% | $2.74B |
| Loss before provision for income taxes | -$200.8M-55.8% | -$128.9M+19.7% | -$160.5M-27.8% | -$125.6M-274.6% | $71.9M+164.5% | -$111.4M-44.2% | -$77.3M | — |
| Provision for (benefit from) income taxes | $43.3M+753.5% | -$6.6M+50.8% | -$13.5M-55.4% | -$8.7M-275.0% | $4.9M+1847.7% | -$283K-174.7% | $379K+100.1% | -$470.0M |
| Net loss | -$244.1M-99.6% | -$122.3M+16.8% | -$147.0M-25.7% | -$116.9M-274.6% | $67.0M+160.3% | -$111.1M-43.1% | -$77.7M+100.0% | -$155.65B |
| Basic net loss per ordinary share (in USD per share) | -$4530.00-99.6% | -$2270.00+17.8% | -$2760.00-11.7% | -$2470.00-263.6% | $1510.00+154.3% | -$2780.00-42.6% | -$1950.00 | — |
| Diluted net loss per ordinary share (in USD per share) | -$4530.00-99.6% | -$2270.00+17.8% | -$2760.00-11.7% | -$2470.00-279.0% | $1380.00+149.6% | -$2780.00-42.6% | -$1950.00 | — |
| Shares used to compute basic net loss per share (in shares) | $53829000.00+0.1% | $53772000.00+1.0% | $53216000.00+12.3% | $47369000.00+7.1% | $44228000.00+10.8% | $39915000.00+0.1% | $39882000.00 | — |
| Shares used to compute diluted net loss per share (in shares) | $53829000.00+0.1% | $53772000.00+1.0% | $53216000.00+12.3% | $47369000.00-2.3% | $48464000.00+21.4% | $39915000.00+0.1% | $39882000.00 | — |
| Collaboration revenue | ||||||||
| Revenue from license and intellectual property | ||||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.